Amir Weiss - Mar 3, 2023 Form 4/A - Amendment Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Chief Accounting Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for Amir Weiss
Stock symbol
TEVA
Transactions as of
Mar 3, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/7/2023, 04:14 PM
Date Of Original Report
Mar 7, 2023
Previous filing
Mar 2, 2023
Next filing
Aug 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TEVA Ordinary Shares 30.2K Mar 3, 2023 Direct F1
holding TEVA Ordinary Shares 40.9K Mar 3, 2023 Direct F1
holding TEVA Ordinary Shares 44.4K Mar 3, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 On March 7, 2023, the reporting person filed a Form 4 which inadvertently reported that, following vesting of certain restricted share units, he owned fewer of the Issuer's Ordinary Shares than he owns. As reported in this amendment, following the three transactions previously reported, he owned 44,423.41 Ordinary Shares.